Competition issues in the kidney dialysis market.
Issues related to oral-only ESRD drugs.
Monitor issues relating to the physician fee schedule rule.
Monitor telehealth issues.
Monitor issues relating to accreditation of dialysis facilities.
Monitor issues relating to VA contracting with dialysis facilities.
Monitor issues relating to Medicare reimbursement for dialysis vascular access services.
Monitor issues relating to Medicare reimbursement for ESRD Seamless Care Organizations (ESCOs).
Monitor issues relating to ESRD Treatment Choices Model.
Monitor Issues relating network adequacy standards for kidney dialysis under Medicare Advantage.
Monitor Issues relating to Medicare Secondary Payer legislation.
Monitor H1-B Visas.
Monitor issues relating to high-skilled immigration.
Duration: September 11, 2017
to
present
General Issues: Health Issues , Immigration , Labor Issues/Antitrust/Workplace
Spending: about $530,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2017: House of Representatives, U.S. Senate, White House Office
Related Foreign Entities:
Fresenius Medical Care AG & Co. KGaA (Homburg, GER); contribution to lobbying: $0; ownership 100%
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Joseph Gibson Chief Minority Counsel, House Judiciary Committee 2007-2008; Chief of Staff, Rep. Lamar Smith 2005-2007; Chief Legislative Counsel & Parliamentarian, House Judiciary Committee 2003-2005; Deputy Asst. Attorney General, Office of Leg. Affairs 2002-2003
Counsel for Legislative & Intergovernmental Affairs Anti-Trust Division, DOJ 2001-2002; Chief Antitrust Counsel, House Judiciary Committee 1997-2001; Counsel, House Judiciary Committee 1995-1997
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, The Gibson Group, LLC lobbied for Fresenius Medical Care North America , earning $20,000. The report was filed on April 22.
Original Filing: 301570455.xml
Lobbying Issues
Competition issues in the kidney dialysis market.
Issues related to oral-only ESRD drugs.
Monitor issues relating to the physician fee schedule rule.
Monitor telehealth issues.
Monitor issues relating to accreditation of dialysis facilities.
Monitor issues relating to VA contracting with dialysis facilities.
Monitor issues relating to Medicare reimbursement for dialysis vascular access services.
Monitor issues relating to Medicare reimbursement for ESRD Seamless Care Organizations (ESCOs).
Monitor issues relating to ESRD Treatment Choices Model.
Monitor Issues relating network adequacy standards for kidney dialysis under Medicare Advantage.
Monitor Issues relating to Medicare Secondary Payer legislation.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor H1-B Visas.
Monitor issues relating to high-skilled immigration.
4th Quarter, 2023
In Q4, The Gibson Group, LLC lobbied for Fresenius Medical Care North America , earning $20,000. The report was filed on Jan. 22.
Original Filing: 301536682.xml
Lobbying Issues
Competition issues in the kidney dialysis market.
Monitor issues relating to the physician fee schedule rule.
Monitor telehealth issues.
Monitor issues relating to accreditation of dialysis facilities.
Monitor issues relating to VA contracting with dialysis facilities.
Monitor issues relating to Medicare reimbursement for dialysis vascular access services.
Monitor issues relating to Medicare reimbursement for ESRD Seamless Care Organizations (ESCOs).
Monitor issues relating to ESRD Treatment Choices Model.
Monitor Issues relating network adequacy standards for kidney dialysis under Medicare Advantage.
Monitor Issues relating to Medicare Secondary Payer legislation.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor H1-B Visas.
Monitor issues relating to high-skilled immigration.
3rd Quarter, 2023
In Q3, The Gibson Group, LLC lobbied for Fresenius Medical Care North America , earning $20,000. The report was filed on Oct. 20, 2023.
Original Filing: 301509969.xml
Lobbying Issues
Monitor competition issues in the kidney dialysis market.
Monitor issues relating to the physician fee schedule rule.
Monitor telehealth issues.
Monitor issues relating to accreditation of dialysis facilities.
Monitor issues relating to VA contracting with dialysis facilities.
Monitor issues relating to Medicare reimbursement for dialysis vascular access services.
Monitor issues relating to Medicare reimbursement for ESRD Seamless Care Organizations (ESCOs).
Monitor issues relating to ESRD Treatment Choices Model.
Monitor Issues relating network adequacy standards for kidney dialysis under Medicare Advantage.
Issues relating to Medicare Secondary Payer legislation.
Lobbying Issues
Monitor H1-B Visas.
Monitor issues relating to high-skilled immigration.
2nd Quarter, 2023
In Q2, The Gibson Group, LLC lobbied for Fresenius Medical Care North America , earning $20,000. The report was filed on July 20, 2023.
Original Filing: 301487666.xml
Lobbying Issues
Monitor competition issues in the kidney dialysis market.
Monitor issues relating to the physician fee schedule rule.
Monitor telehealth issues.
Monitor issues relating to accreditation of dialysis facilities.
Monitor issues relating to VA contracting with dialysis facilities.
Monitor issues relating to Medicare reimbursement for dialysis vascular access services.
Monitor issues relating to Medicare reimbursement for ESRD Seamless Care Organizations (ESCOs).
Monitor issues relating to ESRD Treatment Choices Model.
Monitor Issues relating network adequacy standards for kidney dialysis under Medicare Advantage.
Issues relating to Medicare Secondary Payer legislation.
Lobbying Issues
Monitor H1-B Visas.
Monitor issues relating to high-skilled immigration.
1st Quarter, 2023
In Q1, The Gibson Group, LLC lobbied for Fresenius Medical Care North America , earning $20,000. The report was filed on April 20, 2023.
Original Filing: 301460348.xml
Lobbying Issues
Monitor competition issues in the kidney dialysis market.
Monitor issues relating to the physician fee schedule rule.
Monitor telehealth issues.
Monitor issues relating to accreditation of dialysis facilities.
Monitor issues relating to VA contracting with dialysis facilities.
Monitor issues relating to Medicare reimbursement for dialysis vascular access services.
Monitor issues relating to Medicare reimbursement for ESRD Seamless Care Organizations (ESCOs).
Monitor issues relating to ESRD Treatment Choices Model.
Monitor Issues relating network adequacy standards for kidney dialysis under Medicare Advantage.
Lobbying Issues
Monitor H1-B Visas.
Monitor issues relating to high-skilled immigration.
4th Quarter, 2022
In Q4, The Gibson Group, LLC lobbied for Fresenius Medical Care North America , earning $20,000. The report was filed on Jan. 20, 2023.
Original Filing: 301436759.xml
Lobbying Issues
Monitor competition issues in the kidney dialysis market.
Monitor issues relating to the physician fee schedule rule.
Monitor telehealth issues.
Monitor issues relating to accreditation of dialysis facilities.
Monitor issues relating to VA contracting with dialysis facilities.
Monitor issues relating to Medicare reimbursement for dialysis vascular access services.
Monitor issues relating to Medicare reimbursement for ESRD Seamless Care Organizations (ESCOs).
Monitor issues relating to ESRD Treatment Choices Model.
Monitor Issues relating network adequacy standards for kidney dialysis under Medicare Advantage.
Lobbying Issues
Monitor H1-B Visas.
Monitor issues relating to high-skilled immigration.
Lobbying Issues
Monitor possible legislation to provide liability protection for reopening workplaces after COVID.
Type of Issue
Labor Issues/Antitrust/Workplace
3rd Quarter, 2022
In Q3, The Gibson Group, LLC lobbied for Fresenius Medical Care North America , earning $20,000. The report was filed on Oct. 20, 2022.
Original Filing: 301413001.xml
Lobbying Issues
Monitor competition issues in the kidney dialysis market.
Monitor issues relating to the physician fee schedule rule.
Monitor telehealth issues.
Monitor issues relating to accreditation of dialysis facilities.
Monitor issues relating to VA contracting with dialysis facilities.
Monitor issues relating to Medicare reimbursement for dialysis vascular access services.
Monitor issues relating to Medicare reimbursement for ESRD Seamless Care Organizations (ESCOs).
Monitor issues relating to ESRD Treatment Choices Model.
Monitor Issues relating network adequacy standards for kidney dialysis under Medicare Advantage.
Lobbying Issues
Monitor H1-B Visas.
Monitor issues relating to high-skilled immigration.
Lobbying Issues
Monitor possible legislation to provide liability protection for reopening workplaces after COVID.
Type of Issue
Labor Issues/Antitrust/Workplace
2nd Quarter, 2022
In Q2, The Gibson Group, LLC lobbied for Fresenius Medical Care North America , earning $20,000. The report was filed on July 20, 2022.
Original Filing: 301390064.xml
Lobbying Issues
Monitor competition issues in the kidney dialysis market.
Monitor issues relating to the physician fee schedule rule.
Monitor telehealth issues.
Monitor issues relating to accreditation of dialysis facilities.
Monitor issues relating to VA contracting with dialysis facilities.
Monitor issues relating to Medicare reimbursement for dialysis vascular access services.
Monitor issues relating to Medicare reimbursement for ESRD Seamless Care Organizations (ESCOs).
Monitor issues relating to ESRD Treatment Choices Model.
Monitor Issues relating network adequacy standards for kidney dialysis under Medicare Advantage.
Lobbying Issues
Monitor issues relating to high-skilled immigration.
Lobbying Issues
Monitor possible legislation to provide liability protection for reopening workplaces after COVID.
Type of Issue
Labor Issues/Antitrust/Workplace
1st Quarter, 2022
In Q1, The Gibson Group, LLC lobbied for Fresenius Medical Care North America , earning $20,000. The report was filed on April 20, 2022.
Original Filing: 301365121.xml
Lobbying Issues
Monitor competition issues in the kidney dialysis market.
Issues relating to the physician fee schedule rule.
Monitor telehealth issues.
Monitor issues relating to accreditation of dialysis facilities.
Monitor issues relating to VA contracting with dialysis facilities.
Monitor issues relating to Medicare reimbursement for dialysis vascular access services.
Monitor issues relating to Medicare reimbursement for ESRD Seamless Care Organizations (ESCOs).
Monitor issues relating to ESRD Treatment Choices Model.
Monitor Issues relating network adequacy standards for kidney dialysis under Medicare Advantage.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor H1-B Visas.
Monitor issues relating to high-skilled immigration.
Lobbying Issues
Monitor possible legislation to provide liability protection for reopening workplaces after COVID.
Type of Issue
Labor Issues/Antitrust/Workplace
4th Quarter, 2021
In Q4, The Gibson Group, LLC lobbied for Fresenius Medical Care North America , earning $20,000. The report was filed on Jan. 20, 2022.
Original Filing: 301331476.xml
Lobbying Issues
Monitor competition issues in the kidney dialysis market.
Monitor issues relating to the physician fee schedule rule.
Monitor telehealth issues.
Monitor issues relating to accreditation of dialysis facilities.
Monitor issues relating to VA contracting with dialysis facilities.
Monitor issues relating to Medicare reimbursement for dialysis vascular access services.
Monitor issues relating to Medicare reimbursement for ESRD Seamless Care Organizations (ESCOs).
Monitor issues relating to ESRD Treatment Choices Model.
Monitor Issues relating network adequacy standards for kidney dialysis under Medicare Advantage.
Lobbying Issues
Monitor H1-B Visas.
Monitor issues relating to high-skilled immigration.
Lobbying Issues
Monitor possible legislation to provide liability protection for reopening workplaces after COVID.
Type of Issue
Labor Issues/Antitrust/Workplace
3rd Quarter, 2021
In Q3, The Gibson Group, LLC lobbied for Fresenius Medical Care North America , earning $20,000. The report was filed on Oct. 20, 2021.
Original Filing: 301309088.xml
Lobbying Issues
Competition issues in the kidney dialysis market.
Issues relating to the physician fee schedule rule.
Monitor telehealth issues.
Monitor issues relating to accreditation of dialysis facilities.
Monitor issues relating to VA contracting with dialysis facilities.
Monitor issues relating to Medicare reimbursement for dialysis vascular access services.
Monitor issues relating to Medicare reimbursement for ESRD Seamless Care Organizations (ESCOs).
Monitor issues relating to ESRD Treatment Choices Model.
Monitor Issues relating network adequacy standards for kidney dialysis under Medicare Advantage.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor H1-B Visas.
Monitor issues relating to high-skilled immigration.
Lobbying Issues
Monitor possible legislation to provide liability protection for reopening workplaces after COVID.
Type of Issue
Labor Issues/Antitrust/Workplace
2nd Quarter, 2021
In Q2, The Gibson Group, LLC lobbied for Fresenius Medical Care North America , earning $20,000. The report was filed on July 20, 2021.
Original Filing: 301284145.xml
Lobbying Issues
Competition issues in the kidney dialysis market.
Telehealth issues.
Monitor issues relating to accreditation of dialysis facilities.
Monitor issues relating to VA contracting with dialysis facilities.
Monitor issues relating to Medicare reimbursement for dialysis vascular access services.
Monitor issues relating to Medicare reimbursement for ESRD Seamless Care Organizations (ESCOs).
Monitor issues relating to ESRD Treatment Choices Model.
Monitor Issues relating network adequacy standards for kidney dialysis under Medicare Advantage.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor H1-B Visas.
Monitor issues relating to high-skilled immigration.
Lobbying Issues
Monitor possible legislation to provide liability protection for reopening workplaces after COVID.
Type of Issue
Labor Issues/Antitrust/Workplace
1st Quarter, 2021
In Q1, The Gibson Group, LLC lobbied for Fresenius Medical Care North America , earning $20,000. The report was filed on April 20, 2021.
Original Filing: 301261357.xml
Lobbying Issues
Competition issues in the kidney dialysis market.
Monitor issues relating to accreditation of dialysis facilities.
Monitor issues relating to VA contracting with dialysis facilities.
Monitor issues relating to Medicare reimbursement for dialysis vascular access services.
Monitor issues relating to Medicare reimbursement for ESRD Seamless Care Organizations (ESCOs).
Monitor issues relating to ESRD Treatment Choices Model.
Monitor Issues relating network adequacy standards for kidney dialysis under Medicare Advantage.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor H1-B Visas.
Monitor issues relating to high-skilled immigration.
Lobbying Issues
Monitor possible legislation to provide liability protection for reopening workplaces after COVID.
Type of Issue
Labor Issues/Antitrust/Workplace
4th Quarter, 2020
In Q4, The Gibson Group, LLC lobbied for Fresenius Medical Care North America , earning $20,000. The report was filed on Jan. 20, 2021.
Original Filing: 301238152.xml
Lobbying Issues
Monitor competition issues in the kidney dialysis market.
Monitor issues relating to accreditation of dialysis facilities.
Monitor issues relating to VA contracting with dialysis facilities.
Monitor issues relating to Medicare reimbursement for dialysis vascular access services.
Monitor issues relating to Medicare reimbursement for ESRD Seamless Care Organizations (ESCOs).
Monitor issues relating to ESRD Treatment Choices Model.
Monitor Issues relating network adequacy standards for kidney dialysis under Medicare Advantage.
Lobbying Issues
Monitor H1-B Visas.
Monitor issues relating to high-skilled immigration.
Lobbying Issues
Possible legislation to provide liability protection for reopening workplaces after COVID.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
3rd Quarter, 2020
In Q3, The Gibson Group, LLC lobbied for Fresenius Medical Care North America , earning $20,000. The report was filed on Oct. 20, 2020.
Original Filing: 301217680.xml
Lobbying Issues
Competition issues in the kidney dialysis market.
Monitor issues relating to accreditation of dialysis facilities.
Monitor issues relating to VA contracting with dialysis facilities.
Monitor issues relating to Medicare reimbursement for dialysis vascular access services.
Monitor issues relating to Medicare reimbursement for ESRD Seamless Care Organizations (ESCOs).
Monitor issues relating to ESRD Treatment Choices Model.
Issues relating network adequacy standards for kidney dialysis under Medicare Advantage.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor H1-B Visas.
Monitor issues relating to high-skilled immigration.
Lobbying Issues
Possible legislation to provide liability protection for reopening workplaces after COVID.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
2nd Quarter, 2020
In Q2, The Gibson Group, LLC lobbied for Fresenius Medical Care North America , earning $20,000. The report was filed on July 20, 2020.
Original Filing: 301195004.xml
Lobbying Issues
Competition issues in the kidney dialysis market.
Issues relating to accreditation of dialysis facilities.
Issues relating to VA contracting with dialysis facilities.
Issues relating to Medicare reimbursement for dialysis vascular access services.
Issues relating to Medicare reimbursement for ESRD Seamless Care Organizations (ESCOs).
Issues relating to ESRD Treatment Choices Model.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H1-B Visas.
Issues relating to high-skilled immigration.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2020
In Q1, The Gibson Group, LLC lobbied for Fresenius Medical Care North America , earning $20,000. The report was filed on April 20, 2020.
Original Filing: 301174866.xml
Lobbying Issues
Competition issues in the kidney dialysis market.
Issues relating to accreditation of dialysis facilities.
Issues relating to VA contracting with dialysis facilities.
Issues relating to Medicare reimbursement for dialysis vascular access services.
Issues relating to Medicare reimbursement for ESRD Seamless Care Organizations (ESCOs).
Issues relating to ESRD Treatment Choices Model.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2019
In Q4, The Gibson Group, LLC lobbied for Fresenius Medical Care North America , earning $20,000. The report was filed on Jan. 21, 2020.
Original Filing: 301125900.xml
Lobbying Issues
Competition issues in the kidney dialysis market.
Issues relating to accreditation of dialysis facilities.
Issues relating to VA contracting with dialysis facilities.
Issues relating to Medicare reimbursement for dialysis vascular access services.
Issues relating to Medicare reimbursement for ESRD Seamless Care Organizations (ESCOs).
Issues relating to ESRD Treatment Choices Model.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2019
In Q3, The Gibson Group, LLC lobbied for Fresenius Medical Care North America , earning $20,000. The report was filed on Oct. 21, 2019.
Original Filing: 301073844.xml
Lobbying Issues
Competition issues in the kidney dialysis market.
Issues relating to accreditation of dialysis facilities.
Issues relating to VA contracting with dialysis facilities.
Issues relating to Medicare reimbursement for dialysis vascular access services.
Issues relating to Medicare reimbursement for ESRD Seamless Care Organizations (ESCOs).
Issues relating to ESRD Treatment Choices Model.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2019
In Q2, The Gibson Group, LLC lobbied for Fresenius Medical Care North America , earning $20,000. The report was filed on July 22, 2019.
Original Filing: 301055204.xml
Lobbying Issues
Competition issues in the kidney dialysis market.
Issues relating to accreditation of dialysis facilities.
Issues relating to VA contracting with dialysis facilities.
Issues relating to Medicare reimbursement for dialysis vascular access services.
Issues relating to Medicare reimbursement for ESRD Seamless Care Organizations (ESCOs).
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2019
In Q1, The Gibson Group, LLC lobbied for Fresenius Medical Care North America , earning $20,000. The report was filed on April 22, 2019.
Original Filing: 301034342.xml
Lobbying Issues
Competition issues in the kidney dialysis market.
Issues relating to accreditation of dialysis facilities.
Issues relating to VA contracting with dialysis facilities.
Issues relating to Medicare reimbursement for dialysis vascular access services.
Issues relating to Medicare reimbursement for ESRD Seamless Care Organizations (ESCOs).
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2018
In Q4, The Gibson Group, LLC lobbied for Fresenius Medical Care North America , earning $20,000. The report was filed on Jan. 22, 2019.
Original Filing: 301013344.xml
Lobbying Issues
Competition issues in the kidney dialysis market.
Issues relating to accreditation of dialysis facilities.
Issues relating to VA contracting with dialysis facilities.
Issues relating to Medicare reimbursement for dialysis vascular access services.
Issues relating to Medicare reimbursement for ESRD Seamless Care Organizations (ESCOs).
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2018
In Q3, The Gibson Group, LLC lobbied for Fresenius Medical Care North America , earning $20,000. The report was filed on Oct. 22, 2018.
Original Filing: 300994634.xml
Lobbying Issues
Competition issues in the kidney dialysis market.
Issues relating to accreditation of dialysis facilities.
Issues relating to VA contracting with dialysis facilities.
Issues relating to Medicare reimbursement for dialysis vascular access services.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2018
In Q2, The Gibson Group, LLC lobbied for Fresenius Medical Care North America , earning $20,000. The report was filed on July 20, 2018.
Original Filing: 300973135.xml
Lobbying Issues
Competition issues in the kidney dialysis market.
Issues relating to accreditation of dialysis facilities.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2018
In Q1, The Gibson Group, LLC lobbied for Fresenius Medical Care North America , earning $20,000. The report was filed on April 20, 2018.
Original Filing: 300953449.xml
Lobbying Issues
Competition issues in the kidney dialysis market.
Issues relating to accreditation of dialysis facilities.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2017
In Q4, The Gibson Group, LLC lobbied for Fresenius Medical Care North America , earning $20,000. The report was filed on Jan. 22, 2018.
Original Filing: 300933247.xml
Lobbying Issues
Competition issues in the kidney dialysis market.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2017
In Q3, The Gibson Group, LLC lobbied for Fresenius Medical Care North America , earning $10,000. The report was filed on Oct. 20, 2017.
Original Filing: 300911998.xml
Lobbying Issues
Competition issues in the kidney dialysis market.
Agencies Lobbied
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...